AC
NBP

Armistice Capital’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Armistice Capital’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,768,000
Closed -$7.09M – 212
2022
Q3 		$7.09M Sell
1,768,000
-1,556,000
-47% -$11.8M 0.12% 85
2022
Q2 		$37.6M Buy
+3,324,000
New +$39.8M 0.66% 41

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $100M AUM 90.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Armistice Capital's NBP Position: Q4 2022 in Review

Armistice Capital sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2022, closing a stake of 1,768,000 shares — an estimated $7.09M sold.

Armistice Capital first reported a position in NBP in Q2 2022 and held it in 2 quarters. The position peaked at $37.6M in Q2 2022. 68 funds tracked by Wall St. Rank hold NBP as of Q4 2022.

  • Armistice Capital reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Armistice Capital sold 1,768,000 NovaBridge Biosciences American Depositary Shares shares in Q4 2022, an estimated $7.09M.
  • Armistice Capital first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2022 and held it in 2 quarters.
  • Armistice Capital's NovaBridge Biosciences American Depositary Shares position peaked at $37.6M in Q2 2022.
  • 68 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2022.

Based on Armistice Capital's 13F filing for Q4 2022, filed 14 Feb 2023.